FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma
Qing Tang, Mengfei Xu, Shunqin Long, Yaya Yu, Changju Ma, Rui Wang, Jing Li, Xi Wang, Fang Fang, Ling Han, Wanyin Wu, Sumei Wang
Topics & Concepts
GefitinibViability assayCancer researchCell growthBiologyLung cancerMolecular biologyCellCancerMedicineEpidermal growth factor receptorPathologyBiochemistryGeneticsEpigenetics and DNA MethylationPI3K/AKT/mTOR signaling in cancerHistone Deacetylase Inhibitors Research